Speaker illustration

Doctor Pamela Conley

Portola Pharmaceuticals Inc., South San Francisco (United States of America)

Andexanet alfa reduces betrixaban-induced blood loss in a rabbit liver laceration model of acute bleeding.

Event: ESC CONGRESS 2017

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Prevention general

Thumbnail

Apixaban anticoagulation can be reversed using andexanet alfa in a polytrauma model

Event: ESC CONGRESS 2017

Topic: Basic Science

Session: Cardiovascular care - Biology II

Thumbnail

This platform is supported by

logo Novo Nordisk